Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: results from the EMPA-REG OUTCOME ® trial
Kadowaki, Takashi, Nangaku, Masaomi, Hantel, Stefan, Okamura, Tomoo, von Eynatten, Maximilian, Wanner, Christoph, Koitka-Weber, AudreyLanguage:
english
Journal:
Journal of Diabetes Investigation
DOI:
10.1111/jdi.12971
Date:
November, 2018
File:
PDF, 1.03 MB
english, 2018